Wednesday, September 14, 2016

Cdc meningitis vaccine

Meningococcal Vaccination. Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria. Links with this icon indicate that you are leaving the CDC. The Pneumococcal vaccine can protect agains pneumococcal.


Human papillomavirus (HPV) is a very common virus that can. The vaccine protects against three diseases: measles, mumps,.

CDC recommends a booster dose at age 16. The booster dose gives teens continued protection during the ages when they are at highest risk. There are types of meningococcal vaccines : The MenACWY vaccine for preteens, teens, and children and adults with certain health conditions.


The MenB vaccine for people age years and older who have certain health conditions — or are in an area with an outbreak of serogroup B meningococcal disease. Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-13 and Y. Historically, outbreaks in the meningitis belt were primarily due to serogroup A. Should you get a vaccine for your child or teen? Here is information parents should know.


People who will be working with or around animals (such as veterinarians , wildlife professionals, and researchers).

Vaccination for meningococcal disease is recommended if you plan to visit a destination in the “meningitis belt” of sub-Saharan Africa (see map) during the dry season (December through June), when the disease is more common. All 11- through12-year-old adolescents should be vaccinated with meningococcal conjugate vaccine (MCV4). Anyone who has been exposed to meningitis during an outbreak.


Anyone traveling to or living where meningitis is common, such as in sub-Saharan Africa. Whenever sporadic or cluster cases or outbreaks of meningococcal disease occur in the US, chemoprophylaxis is the principal means of preventing secondary cases in household and other close contacts of individuals with invasive disease. There are currently three vaccines available in the US to prevent meningococcal disease, all quadrivalent in nature, targeting serogroups A, C, W-13 and Y: two conjugate vaccines (MCV-4), Menactra and Menveo, and. MPSV-4), Menomune, produced by Sanofi Pasteur.


Pneumococcal conjugate vaccine (PCV13), Haemophilus influenzae type b vaccine , meningococcal conjugate vaccine , and meningococcal B vaccine should be given days before splenectomy, if possible. Doses given during the weeks (days) before surgery can be counted as valid. Young children have less developed immune systems than older age groups which means that they are at increased risk. Vaccination is a safe way to develop protection against some common causes of disease.


The Centers for Disease Control and Prevention ( CDC ) cannot attest to the accuracy of a non-federal website. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. By this time, data on vaccine effectiveness had. The meningitis vaccine called Menactrameningitis vaccine called Menactra was approved by the FDA in January.


Candidate vaccines include capsular polysaccharides complexed with meningococcal outer-membrane proteins or covalently linked to carrier proteins. The Vaccine is an educational initiative for the CDC -recommended second dose of meningococcal meningitis vaccine. In response, the CDC announced that persons years of age and older recommended to receive meningococcal vaccination be administered meningococcal conjugate vaccine.

This recommendation was made despite acknowledging that neither available meningococcal conjugate vaccine is FDA approved for use in persons older than years of age. The disease is serious and can be fatal, though about of patients recover with antibiotics. A serogroup B meningococcal (Men B) vaccine series may be administered to adolescents and young adults through years of age to provide short term protection against most strains of serogroup B meningococcal disease.


The preferred age for Men B vaccination is through years of age.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Popular Posts